J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fidge, N. H.
Right arrow Articles by McCullagh, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fidge, N. H.
Right arrow Articles by McCullagh, P. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 22, 138-146, Copyright © 1981 by Lipid Research, Inc.

ARTICLES

Studies on the apoproteins of rat lymph chylomicrons: characterization and metabolism of a new chylomicron-associated apoprotein

NH Fidge and PJ McCullagh

The apoprotein composition of rat lymph chylomicrons and very low density lipoprotein (VLDL) was investigated following isolation and purification by preparative gel electrophoresis. The medium molecular weight apoproteins in the 27,000-60,000 range were characterized by electrophoretic mobility, immunochemical identification, amino acid composition, and molecular weight determination. In addition to three previously identified apoproteins, A-I, E, and A-IV, present in both rat serum high density lipoproteins (HDL) and lymph chylomicrons, a fourth peptide of molecular weight 59,000 was always a consistent major component of lymph VLDL washed free of serum protein contaminants by repeated ultracentrifugation. The protein formed complexes with phosphatidylcholine vesicles, was amphipathic in nature, and, when injected into rats, became associated with serum HDL and lymph chylomicrons. It was removed from chylomicrons after gel filtration through agarose columns but not after repeated ultracentrifugation; it differed slightly in amino acid composition and did not show immunochemical identity against antisera to any other apoprotein. The results of in vivo studies suggest that the protein preferentially associates with lymph chylomicrons and thus may play some important role in the metabolism of exogenous triglyceride transport. Since A-I, A-II, and A-IV apoproteins are also integral components of lymph chylomicrons, we suggest that the protein be designated A-V apoprotein. The distribution of A-I, E, A-IV, and A-V in serum HDL and lymph VLDL was approximately 54, 10, 12, and 0%, and 22, 3, 19, and 22%, prospectively.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
M. Mihovilovic, J. B. Robinette, R. M. DeKroon, P. M. Sullivan, and W. J. Strittmatter
High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDL
J. Lipid Res., April 1, 2007; 48(4): 806 - 815.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1981 by the American Society for Biochemistry and Molecular Biology.